QQ客服 官方微博 反馈留言

	A design of phase II cancer trials using total and complete response endpoints
	Lu, Y ; Jin, H ; Lamborn, KR
	2005
关键词	phase II trial optimal two-stage design trinomial 2-STAGE DESIGNS
英文摘要	Phase II clinical trials in oncology are used for initial evaluation of the therapeutic efficacy of a new treatment regimen. Simon's two-stage design based on total response (TR) rate is commonly used for such trials. Several authors have proposed alternative strategies to consider either response and toxicity or response and early progression. Because TR consists of both partial response (PR) and complete response (CR) and these two types of responses have different effects on subsequent patient outcome, Lin and Chen proposed a flexible design that is based on a weighted average of PR and CR rates as a way to recognize the differential significance of the two levels of response. Panageas and colleagues, on the other hand, used a trinomial model and direct search to consider a rejection region for PR and CR separately. In this paper, we reformat their hypotheses to assess efficacy based on TR and CR. A new two-stage optimum phase II trial design based on TR and CR is developed. We provide guides on searching the stopping and rejecting regions and on determining sample size. An example of a phase II trial for glioblastomas treatment is presented. In this trial, physicians would be interested in either stable disease (SD), PR, or CR as an indication of efficacy. However, because PR and CR rarely occur, observation of any PR or CR will lean towards acceptance of the treatment. Our design has the advantage of being close to the traditional Simon two-stage design while still having the flexibility to treat responses (PR and CR in this example) differently than SD. Copyright (C) 2005 John Wiley & Sons, Ltd.; Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability; SCI(E); 16; ARTICLE; 20; 3155-3170; 24
语种	英语
出处	SCI
出版者	医学统计学
内容类型	其他
源URL	[http://hdl.handle.net/20.500.11897/253872]
专题	数学科学学院
推荐引用方式 GB/T 7714	Lu, Y,Jin, H,Lamborn, KR. A design of phase II cancer trials using total and complete response endpoints. 2005-01-01.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。